Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼Ò¾Æ »ýü ºÎºÐ °£ÀÌ½Ä ÈÄÀÇ ¼ºÀå ºÐ¼® Analysis of Linear Growth in Children after Living-related Liver Transplantation

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2001³â 4±Ç 1È£ p.63 ~ 70
ÀÓ¼±Èñ, À±ÇýÁø, ¼­¿µ¹Ì, ÃÖº¸È­, ±è°æ¸ð, ÀÌ¿µÁÖ, À̽±Ô,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÓ¼±Èñ ( Rim Sun-Hee ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç

À±ÇýÁø ( Yun Hye-Jin ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
¼­¿µ¹Ì ( Suh Young-Mee ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
ÃÖº¸È­ ( Choi Bo-Hwa ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
±è°æ¸ð ( Kim Kyung-Mo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
ÀÌ¿µÁÖ ( Lee Young-Joo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¿Ü°úÇб³½Ç
À̽±Ԡ( Lee Sung-Gyu ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¿Ü°úÇб³½Ç

Abstract

¸ñ Àû: º» ¿¬±¸´Â »ýü ºÎºÐ °£À̽ÄÀÌ È¯¾ÆÀÇ ¼ºÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÏ¿© ºÐ¼®ÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ ¹ý: 1994³â 10¿ùºÎÅÍ 1999³â 2¿ù±îÁö ¼­¿ïÁß¾Óº´¿ø¿¡¼­ ½ÃÇàµÈ »ýü ºÎºÐ °£À̽ÄÀ» ¹ÞÀº ȯ¾Æ Áß »ýÁ¸À²ÀÌ 1³â ÀÌ»óÀΠȯ¾Æ 36¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ÀÌ½Ä ÀüÈÄ ¿Ü·¡¿¡¼­ ÃßÀû °üÂûÇÏ¸ç °èÃøÇÑ ½ÅÀå ±â·ÏÀ» ÈÄÇâÀûÀ¸·Î Á¶»çÇÏ¿© ÀÌ½Ä ÈÄ °³¿ù¿¡ µû¸¥ Æò±Õ zH¸¦ ºñ±³ÇÏ¿´´Ù. ¶ÇÇÑ ÀÌ½Ä ¿¬·ÉÀÌ 6¼¼ ÀÌÇÏ·Î »çÃá±â ±Þ¼ºÀåÀÇ ¿µÇâÀÌ ¹èÁ¦µÈ ¼Ò¾Æ¿¡¼­ÀÇ ÀÌ½Ä ÈÄ ¼ºÀå º¯È­¿Í ¿øÀÎ Áúȯ, ÀÌ½Ä Àü ¼ºÀå Áö¿¬, °£À̽ÄÆíÀÇ ±â´É, ¸é¿ª ¾ïÁ¦Á¦ÀÇ Á¾·ù¿¡ µû¸¥ ÀÌ½Ä ÈÄ ¼ºÀå º¯È­¿¡ ´ëÇØ ºÐ¼®ÇÏ¿´´Ù.

°á °ú: Àüü ȯ¾ÆÀÇ Æò±Õ zH´Â ÀÌ½Ä Àü 1.58¿¡¼­ ÀÌ½Ä ÈÄ 24°³¿ù° 0.33À¸·Î ÇöÀúÇÏ°Ô Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ÀÌ·ç¾îÁüÀ» º¸¿´´Ù(p£¼0.05). »çÃá±â ¼ºÀåÀÇ ±ÞÁõ¿¡ ÀÇÇÑ ½ÅÀåÀ» ¹èÁ¦Çϱâ À§ÇØ ÀÌ½Ä ´ç½Ã ³ªÀÌ°¡ 6¼¼ ÀÌÇÏ¿´´ø ȯ¾Æµé¿¡¼­ ºñ±³ÇÑ Æò±Õ zHµµ ÀÌ½Ä ÈÄ ½ÅÀåÀÇ ¼ºÀåÀ» º¸¿´´Ù(p£¼0.05). ¸¸¼º ÁúȯÀÌ ÀÖ´Â °æ¿ì ÀÌ½Ä Àü¿¡ ºñÇØ ÀÌ½Ä ÈÄ ¼ºÀåÀÌ Çâ»óµÇ¾ú°í Àü°Ý¼º °£¿°ÀÇ °æ¿ì ÀÌ½Ä ÈÄ¿¡µµ Áö¼ÓÀûÀÎ ¼ºÀåÀÌ À¯ÁöµÇ¾ú´Ù. ÀÌ½Ä Àü ¼ºÀå Áö¿¬ÀÌ ÀÖ¾ú´ø ȯ¾ÆÀÇ °æ¿ì(Æò±Õ zH= 2.70) ÀÌ½Ä ÈÄ¿¡ µû¶óÀâ±â ¼ºÀåÀÌ ÀÌ·ç¾îÁ³°í Á¤»óÀûÀÎ ¼ºÀåÀ» º¸¿´´ø °æ¿ì ÀÌ½Ä ÈÄ¿¡µµ ¼ºÀåÀÌ Áö¼ÓÀûÀ¸·Î À¯ÁöµÇ¾ú´Ù. ¸¸¼º ÀÌ½Ä °ÅºÎ¹ÝÀÀÀ̳ª PTLD °°Àº À̽ÄÆíÀÇ °£±â´É Àå¾Ö°¡ µ¿¹ÝµÈ °æ¿ì¿¡´Â ÀÌ½Ä ÈÄ ¼ºÀåÀÇ Áö¿¬À» º¸¿´´Ù. ¸é¿ª ¾ïÁ¦Á¦ÀÇ Á¾·ù¿¡ µû¸¥ ¼ºÀåÀÇ º¯È­¿¡´Â Åë°èÇÐÀûÀ¸·Î À¯ÀÇÇÑ Â÷ÀÌ´Â º¸ÀÌÁö ¾Ê¾Ò´Ù
.
°á ·Ð: »ýü ºÎºÐ °£À̽ÄÀº ¼º°øÀûÀÎ °£À̽ÄÀ» ÅëÇØ Àå±â »ýÁ¸·üÀÇ Áõ°¡ »Ó¸¸ ¾Æ´Ï¶ó ¼ú ÈÄ Á¤»óÀûÀΠȯ¾ÆÀÇ ¼ºÀåÀ» ±â´ëÇØ º¼ ¼ö ÀÖ´Ù.

Purpose: The aim of this study is to evaluate the effective role of living-related liver transplantation (LRLT) on posttransplant linear growth in children.

Methods: Thirty six children were enrolled who received LRLT at Asan Medical Center from December, 1994 to February, 1999 and showed more than one-year postoperative survival. Mean height standard deviation score (zH) was analyzed according to medical records including heights during pretransplant and posttransplant follow-up periods.

Results: zH of total children showed significant linear growth after LRLT from 1.58 to 0.33 at 24 posttransplant month (p£¼0.05). zH in children under 6 years of age, to exclude the effect of adolescent linear growth spurt, showed increment in height (p£¼0.05). Linear growth of children with liver cirrhosis improved and that with fulminant hepatitis was matained same. While stunted children (mean zH= 2.30) achieved good catch-up growth after transplantation, children with normal growth remained same. Children with significant hepatic dysfunction after LRLT such as chronic rejection or posttransplant lymphoproliferative disorder showed retarded posttrasplant linear growth. There was no statistical difference according to the type of immunosuppressants.

Conclusion: LRLT resulted in adequate or catch-up linear growth in children with acute, chronic and metabolic liver disease. Successful LRLT suggested to be a promising option not only in longterm survival but also in normal linear growth.

Å°¿öµå

Living-related liver transplantation;Child;Linear growth

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS